This week, Google Glass gets a second chance, regular intense exercise can lead to arterial plaques, and research questions if at-home blood sugar monitoring is worth the burden.
Ambitious journalism from ProPublica shares the stories of women who died from pregnancy-related complications, while Slate examines how data from our medical devices can be used against us in a court of law.
Egg donors face serious — and undocumented — consequences and Stanford University researchers share the results of a digital step-tracking study.
Maternal mortality rates in California plummet and 3 former US Surgeons General have called for the end of involuntary medical procedures on intersex infants.
This week, biotech companies examine alternatives to pancreas transplants for T1D and researchers analyze cardiovascular risk profile in conjunction with thyroid disease.
This week, more breastfeeding benefits, the downside of low BMI, and a profile of "the littlest lobbyist."
This week, the latest in islet cell transplantation, the "Uberization of medicine," and a possible link between Three Mile Island and thyroid cancer incidence.
This week, an AztraZeneca phase 3b trial yields positive results for type 2 diabetes therapy, researchers identify the molecular mechanism behind thyroid changes in hyperthyroidism, and the American Academy of Pediatrics revises a years-old dietary recommendation
This week, an NPR investigation highlights the sorely lacking focus of maternal health during pregnancy, and fennel takes the stage as a potential alternative to hormone therapy for postmenopausal symptoms.
In this week's super-sized Handoff, Endocrinology Advisor rounds up the most interesting news from the last month, with highlights including black market insulin, exercise addiction, and potential repercussions of the AHCA.
This week, find out which dietary changes may affect diabetes, learn about a genetic risk factor for hip fracture, and how older mothers are faring compared with their younger counterparts.
This week, researchers uncovered a rare genetic predisposition to thyroid cancer, The Endocrine Society released a clinical guideline for functional hypothalamic amenorrhea, and clinical trial data questions the efficacy of testosterone therapy for "low T."
This week, research challenges decades-old pregnancy advice, revisit commonly held exercise targets, and reexamine the benefits of wearing a continuous glucose monitor in patients without type 1 diabetes.
This week, read about a revolutionary option for blood glucose testing, influencers of health insurance customer satisfaction, and a Girl Scout cookie nutritional analysis.
This week, the GOP proposes a plan to repeal and replace the ACA, Silicon Valley tackles type 2 diabetes, and patients share their thoughts on social media sharing.
The Handoff is back with next steps on the ACA repeal, an examination of our love of vitamin D supplementation, and how to reduce memory loss in menopause.
This week, Senate Democrats continue their probe into Representative Tom Price, Americans share their concerns and hopes surrounding the promised ACA repeal, and learn how your sports team's win or loss affects your waistline.
In this week's Handoff, read about the FDA's approval of a new indication for a type 2 diabetes drug, and more.
Endocrinology Advisor Articles
- ADA Releases Updated Guidelines for Managing Pediatric Type 1 Diabetes
- Relationship Between HbA1c and Coronary Artery Disease
- Intermittent vs Continuous Energy-Restricted Diet: Effects on Glycemic Control and Weight Loss T2D
- The Obesity Paradox in Diabetes: Conceptual and Clinical Approaches
- Nonfunctioning Adrenal Incidentaloma Associated With Metabolic Syndrome
- Self-Administered Contraceptive Vaginal System Approved for Up to 1 Year of Use
- Predictors of Weight Loss in Postpartum Women With Gestational Diabetes
- Genetic Screening May Predict Osteoporosis, Fracture Risk
- DPP-4 Inhibitors and Incidence of Rheumatoid Arthritis in Type 2 Diabetes
- AMA Adopts Policy on Augmented Intelligence